Literature DB >> 28300602

YEATS Domain-A Histone Acylation Reader in Health and Disease.

Dan Zhao1, Yuanyuan Li1, Xiaozhe Xiong1, Zhonglei Chen1, Haitao Li2.   

Abstract

Histone post-translational modifications (PTMs) carry an epigenetic layer of message to regulate diverse cellular processes at the chromatin level. Many of these PTMs are selectively recognized by dedicated effector proteins for normal cell growth and development, while dysregulation of these recognition events is often implicated in human diseases, notably cancer. Thus, it is fundamentally important to elucidate the regulatory mechanism(s) underlying the readout of PTMs on histones. The Yaf9, ENL, AF9, Taf14, Sas5 (YEATS) domain is an emerging reader module that selectively recognizes histone lysine acylation with a preference for crotonylation over acetylation. In the review, we discuss the recognition of histone acylations by the YEATS domain and the biological significance of this readout from multiple perspectives.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  YEATS domain; aromatic-π stacking; epigenetic regulation; histone acylation; lysine crotonylation

Mesh:

Substances:

Year:  2017        PMID: 28300602     DOI: 10.1016/j.jmb.2017.03.010

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  23 in total

1.  Kinetic and high-throughput profiling of epigenetic interactions by 3D-carbene chip-based surface plasmon resonance imaging technology.

Authors:  Shuai Zhao; Mo Yang; Wenfei Zhou; Baichao Zhang; Zhiqiang Cheng; Jiaxin Huang; Min Zhang; Zhiyou Wang; Rui Wang; Zhonglei Chen; Jinsong Zhu; Haitao Li
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-14       Impact factor: 11.205

Review 2.  ENL: structure, function, and roles in hematopoiesis and acute myeloid leukemia.

Authors:  Jianbiao Zhou; Yvonne Ng; Wee-Joo Chng
Journal:  Cell Mol Life Sci       Date:  2018-07-31       Impact factor: 9.261

3.  ENLightening YEATS in antagonizing polycomb repression.

Authors:  Daisuke Nakada
Journal:  Blood       Date:  2018-02-08       Impact factor: 22.113

Review 4.  Epigenetic drug discovery: a success story for cofactor interference.

Authors:  A Ganesan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-05       Impact factor: 6.237

Review 5.  Targeting epigenetic protein-protein interactions with small-molecule inhibitors.

Authors:  Brian M Linhares; Jolanta Grembecka; Tomasz Cierpicki
Journal:  Future Med Chem       Date:  2020-06-19       Impact factor: 3.808

6.  Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1.

Authors:  Xiaomin Ni; David Heidenreich; Thomas Christott; James Bennett; Moses Moustakim; Paul E Brennan; Oleg Fedorov; Stefan Knapp; Apirat Chaikuad
Journal:  ACS Med Chem Lett       Date:  2019-11-25       Impact factor: 4.345

7.  Identification of Uncharacterized Components of Prokaryotic Immune Systems and Their Diverse Eukaryotic Reformulations.

Authors:  A Maxwell Burroughs; L Aravind
Journal:  J Bacteriol       Date:  2020-11-19       Impact factor: 3.490

8.  Structure-guided development of YEATS domain inhibitors by targeting π-π-π stacking.

Authors:  Xin Li; Xiao-Meng Li; Yixiang Jiang; Zheng Liu; Yiwen Cui; Ka Yi Fung; Stan H E van der Beelen; Gaofei Tian; Liling Wan; Xiaobing Shi; C David Allis; Haitao Li; Yuanyuan Li; Xiang David Li
Journal:  Nat Chem Biol       Date:  2018-10-29       Impact factor: 15.040

Review 9.  Multifaceted roles of YEATS domain-containing proteins and novel links to neurological diseases.

Authors:  Ranchana Yeewa; Pawita Chaiya; Salinee Jantrapirom; Vorasuk Shotelersuk; Luca Lo Piccolo
Journal:  Cell Mol Life Sci       Date:  2022-03-12       Impact factor: 9.261

10.  Development of potent dimeric inhibitors of GAS41 YEATS domain.

Authors:  Dymytrii Listunov; Brian M Linhares; EunGi Kim; Alyssa Winkler; Miranda L Simes; Sidney Weaver; Hyo Je Cho; Alexandrea Rizo; Sergey Zolov; Venkateshwar G Keshamouni; Jolanta Grembecka; Tomasz Cierpicki
Journal:  Cell Chem Biol       Date:  2021-07-21       Impact factor: 8.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.